Microsatellite Instability Testing
The latest news on microsatellite instability testing.
Tempus Gains FDA Premarket Approval for NGS Solid Tumor Profiling Test
The xT CDx is a 648-gene next-generation sequencing test that can help guide treatments for colorectal cancer patients with targeted therapies.
AACR Studies Flag Molecular Differences in Colorectal Cancer Patients of African, European Ancestry
Data presented at the meeting underscored the importance of studying diverse populations in order to improve equity in precision oncology.
Merck Nabs Full FDA Approval for Keytruda in MSI-High, dMMR Solid Tumors
The conversion from accelerated to full approval marks the first time the FDA has granted full approval to an immunotherapy in a tumor-agnostic indication.
Compugen Begins Trial of TIGIT, PVRIG Inhibitors With Keytruda in Colorectal Cancer
The firm will explore the efficacy of the TIGIT inhibitor alone, and with the PVRIG and checkpoint inhibitors in patients with metastatic, microsatellite-stable colorectal cancer.
Tachyon Therapeutics Begins Phase I Trial of KDM4 Inhibitor
The company received funding from investors and a grant from the California Institute for Regenerative Medicine to support the trial.